Next-generation sequencing for mitochondrial disorders

British Journal of Pharmacology

Volumn 171, Issue 8, 2014, Pages 1837-1853

  Carroll, C J ^a   Brilhante, V ^a   Suomalainen, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

diagnosis; exome; mitochondria; mitochondrial disease; next generation sequencing

Indexed keywords

MITOCHONDRIAL DNA;

BIOINFORMATICS; DATA PROCESSING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA SEQUENCE; EXOME SEQUENCING; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ANALYZER; GENETIC DATABASE; GENETIC PROCEDURES; GENETIC VARIABILITY; HUMAN; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TARGETED EXOME SEQUENCING; VALIDATION PROCESS; WHOLE EXOME CAPTURE KIT; WHOLE EXOME SEQUENCING; EXOME; GENETICS; HIGH THROUGHPUT SEQUENCING; MITOCHONDRIAL DISEASES; PROCEDURES;

EXOME; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MITOCHONDRIAL DISEASES; SEQUENCE ANALYSIS, DNA;

EID: 84897465412     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12469     Document Type: Review

References (134)

1. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. (2012). An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56-65.
2. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. (2010). A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
3. Bandelt HJ, Achilli A, Kong QP, Salas A, Lutz-Bonengel S, Sun C, et al. (2005). Low 'penetrance' of phylogenetic knowledge in mitochondrial disease studies. Biochem Biophys Res Commun 333: 122-130.
4. Bannai H, Tamada Y, Maruyama O, Nakai K, Miyano S, (2002). Extensive feature detection of N-terminal protein sorting signals. Bioinformatics 18: 298-305.
5. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, et al. (2011). Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3: 65ra64.
6. Berger I, Ben-Neriah Z, Dor-Wolman T, Shaag A, Saada A, Zenvirt S, et al. (2011). Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab 104: 517-520.
7. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR, (2002). Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59: 1406-1411.
8. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. (2007). Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39: 776-780.
9. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, et al. (1995). Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11: 144-149.
10. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, et al. (2000). Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18: 630-634.
11. Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, et al. (2012). Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 4: 118ra110.
12. Carroll CJ, Isohanni P, Poyhonen R, Euro L, Richter U, Brilhante V, et al. (2013). Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy. J Med Genet 50: 151-159.
13. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 106: 19096-19101.
14. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP, (2012). Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7: e46688.
15. Claros MG, Vincens P, (1996). Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur J Biochem 241: 779-786.
16. Conrad DF, Keebler JE, DePristo MA, Lindsay SJ, Zhang Y, Casals F, et al. (2011). Variation in genome-wide mutation rates within and between human families. Nat Genet 43: 712-714.
17. Cui H, Li F, Chen D, Wang G, Truong CK, Enns GM, et al. (2013). Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders. Genet Med 15: 388-394.
18. Danhauser K, Sauer SW, Haack TB, Wieland T, Staufner C, Graf E, et al. (2012). DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am J Hum Genet 91: 1082-1087.
19. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
20. DiMauro S, Schon EA, (2003). Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656-2668.
21. Edvardson S, Porcelli V, Jalas C, Soiferman D, Kellner Y, Shaag A, et al. (2013). Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter. J Med Genet 50: 240-245.
22. Elo JM, Yadavalli SS, Euro L, Isohanni P, Gotz A, Carroll CJ, et al. (2012). Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 21: 4521-4529.
23. Emanuelsson O, Nielsen H, Brunak S, von Heijne G, (2000). Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol 300: 1005-1016.
24. Falk MJ, Pierce EA, Consugar M, Xie MH, Guadalupe M, Hardy O, et al. (2012). Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome. Discov Med 14: 389-399.
25. Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, et al. (2013). Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet 21: 528-534.
26. Fromer M, Moran JL, Chambert K, Banks E, Bergen SE, Ruderfer DM, et al. (2012). Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet 91: 597-607.
27. Galmiche L, Serre V, Beinat M, Assouline Z, Lebre AS, Chretien D, et al. (2011). Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat 32: 1225-1231.
28. Garone C, Rubio JC, Calvo SE, Naini A, Tanji K, Dimauro S, et al. (2012). MPV17 mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions. Arch Neurol 69: 1648-1651.
29. Gerards M, Kamps R, van Oevelen J, Boesten I, Jongen E, de Koning B, et al. (2013). Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. Brain 136 (Pt 3): 882-890.
30. Ghezzi D, Baruffini E, Haack TB, Invernizzi F, Melchionda L, Dallabona C, et al. (2012). Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am J Hum Genet 90: 1079-1087.
31. Glazov EA, Zankl A, Donskoi M, Kenna TJ, Thomas GP, Clark GR, et al. (2011). Whole-exome re-sequencing in a family quartet identifies POP1 mutations as the cause of a novel skeletal dysplasia. PLoS Genetics 7: e1002027.
32. Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, et al. (2009). Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 27: 182-189.
33. Gonzaga-Jauregui C, Lupski JR, Gibbs RA, (2012). Human genome sequencing in health and disease. Annu Rev Med 63: 35-61.
34. Gonzalez-Perez A, Lopez-Bigas N, (2011). Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88: 440-449.
35. Gotz A, Tyynismaa H, Euro L, Ellonen P, Hyotylainen T, Ojala T, et al. (2011). Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88: 635-642.
36. Guo Y, Li J, Li CI, Shyr Y, Samuels DC, (2013). MitoSeek: extracting mitochondria information and performing high-throughput mitochondria sequencing analysis. Bioinformatics 29: 1210-1211.
37. Haack TB, Danhauser K, Haberberger B, Hoser J, Strecker V, Boehm D, et al. (2010). Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet 42: 1131-1134.
38. Haack TB, Rolinski B, Haberberger B, Zimmermann F, Schum J, Strecker V, et al. (2013). Homozygous missense mutation in BOLA3 causes multiple mitochondrial dysfunctions syndrome in two siblings. J Inherit Metab Dis 36: 55-62.
39. Holt IJ, Harding AE, Morgan-Hughes JA, (1988). Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717-719.
40. Horvath R, Holinski-Feder E, Neeve VC, Pyle A, Griffin H, Ashok D, et al. (2012). A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy. Mov Disord 27: 789-793.
41. Hu J, Ng PC, (2012). Predicting the effects of frameshifting indels. Genome Biol 13: R9.
42. Janer A, Antonicka H, Lalonde E, Nishimura T, Sasarman F, Brown GK, et al. (2012). An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet 91: 737-743.
43. Jenkinson EM, Rehman AU, Walsh T, Clayton-Smith J, Lee K, Morell RJ, et al. (2013). Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am J Hum Genet 92: 605-613.
44. Jonckheere AI, Renkema GH, Bras M, van den Heuvel LP, Hoischen A, Gilissen C, et al. (2013). A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy. Brain 136 (Pt 5): 1544-1554.
45. Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP, et al. (2000). Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289: 782-785.
46. Kennerson ML, Yiu EM, Chuang DT, Kidambi A, Tso SC, Ly C, et al. (2013). A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene. Hum Mol Genet 22: 1404-1416.
47. Kevelam SH, Rodenburg RJ, Wolf NI, Ferreira P, Lunsing RJ, Nijtmans LG, et al. (2013). NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern. Neurology 80: 1577-1583.
48. Kondrashov AS, (2003). Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum Mutat 21: 12-27.
49. Konovalova S, Tyynismaa H, (2013). Mitochondrial aminoacyl-tRNA synthetases in human disease. Mol Genet Metab 108: 206-211.
50. Kornblum C, Nicholls TJ, Haack TB, Scholer S, Peeva V, Danhauser K, et al. (2013). Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nat Genet 45: 214-219.
51. Kruglyak L, Nickerson DA, (2001). Variation is the spice of life. Nat Genet 27: 234-236.
52. Krumm N, Sudmant PH, Ko A, O'Roak BJ, Malig M, Coe BP, et al. (2012). Copy number variation detection and genotyping from exome sequence data. Genome Res 22: 1525-1532.
53. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. (2009). Circos: an information aesthetic for comparative genomics. Genome Res 19: 1639-1645.
54. Kumar P, Henikoff S, Ng PC, (2009). Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073-1081.
55. Kumar S, Dudley JT, Filipski A, Liu L, (2011). Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations. Trends Genet 27: 377-386.
56. Lamperti C, Fang M, Invernizzi F, Liu X, Wang H, Zhang Q, et al. (2012). A novel homozygous mutation in SUCLA2 gene identified by exome sequencing. Mol Genet Metab 107: 403-408.
57. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. (2001). Initial sequencing and analysis of the human genome. Nature 409: 860-921.
58. Leamon JH, Lee WL, Tartaro KR, Lanza JR, Sarkis GJ, deWinter AD, et al. (2003). A massively parallel PicoTiterPlate based platform for discrete picoliter-scale polymerase chain reactions. Electrophoresis 24: 3769-3777.
59. Lee HJ, Park J, Nakhro K, Park JM, Hur YM, Choi BO, et al. (2012). Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. J Peripher Nerv Syst 17: 418-421.
60. Li H, Durbin R, (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
61. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. (2009). The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078-2079.
62. Li M, Schroeder R, Ko A, Stoneking M, (2012). Fidelity of capture-enrichment for mtDNA genome sequencing: influence of NUMTs. Nucleic Acids Res 40: e137.
63. Li MX, Kwan JS, Bao SY, Yang W, Ho SL, Song YQ, et al. (2013). Predicting Mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies. PLoS Genetics 9: e1003143.
64. Lieber DS, Vafai SB, Horton LC, Slate NG, Liu S, Borowsky ML, et al. (2012). Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Med Genet 13: 3.
65. Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, Hershman SG, et al. (2013). Targeted exome sequencing of suspected mitochondrial disorders. Neurology 80: 1762-1770.
66. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B, (1962). A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 41: 1776-1804.
67. Lygerou Z, Mitchell P, Petfalski E, Seraphin B, Tollervey D, (1994). The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev 8: 1423-1433.
68. McCormick E, Place E, Falk MJ, (2013). Molecular genetic testing for mitochondrial disease: from one generation to the next. Neurotherapeutics 10: 251-261.
69. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. (2010). The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
70. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
71. Marina AD, Schara U, Pyle A, Moller-Hartmann C, Holinski-Feder E, Abicht A, et al. (2012). NDUFS8-related complex I deficiency extends phenotype from 'PEO Plus' to Leigh syndrome. JIMD Rep 10: 17-22.
72. Marti-Masso JF, Ruiz-Martinez J, Makarov V, Lopez de Munain A, Gorostidi A, Bergareche A, et al. (2012). Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystonia. Hum Genet 131: 435-442.
73. Maxam AM, Gilbert W, (1977). A new method for sequencing DNA. Proc Natl Acad Sci U S A 74: 560-564.
74. Mayr JA, Freisinger P, Schlachter K, Rolinski B, Zimmermann FA, Scheffner T, et al. (2011). Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89: 806-812.
75. Mayr JA, Haack TB, Graf E, Zimmermann FA, Wieland T, Haberberger B, et al. (2012). Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet 90: 314-320.
76. Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, et al. (2012). Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet 44: 740-742.
77. Mitra RD, Church GM, (1999). In situ localized amplification and contact replication of many individual DNA molecules. Nucleic Acids Res 27: e34.
78. Mitra RD, Butty VL, Shendure J, Williams BR, Housman DE, Church GM, (2003). Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci U S A 100: 5926-5931.
79. Miyake N, Yano S, Sakai C, Hatakeyama H, Matsushima Y, Shiina M, et al. (2013). Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation. Hum Mutat 34: 446-452.
80. Morava E, van den Heuvel L, Hol F, de Vries MC, Hogeveen M, Rodenburg RJ, et al. (2006). Mitochondrial disease criteria: diagnostic applications in children. Neurology 67: 1823-1826.
81. Neeve VC, Pyle A, Boczonadi V, Gomez-Duran A, Griffin H, Santibanez-Koref M, et al. (2013). Clinical and functional characterisation of the combined respiratory chain defect in two sisters due to autosomal recessive mutations in MTFMT. Mitochondrion 13: 743-748.
82. Ng PC, Henikoff S, (2003). SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
83. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461: 272-276.
84. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. (2010). Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 42: 30-35.
85. van Oven M, Kayser M, (2009). Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30: E386-E394.
86. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, et al. (2008). A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123.
87. Palotie A, Widen E, Ripatti S, (2013). From genetic discovery to future personalized health research. New Biotechnol 30: 291-295.
88. Parson W, Strobl C, Huber G, Zimmermann B, Gomes SM, Souto L, et al. (2013). Evaluation of next generation mtGenome sequencing using the Ion Torrent Personal Genome Machine (PGM). Forensic Sci Int Genet 7: 543-549.
89. Picardi E, Pesole G, (2012). Mitochondrial genomes gleaned from human whole-exome sequencing. Nat Methods 9: 523-524.
90. Pierce SB, Chisholm KM, Lynch ED, Lee MK, Walsh T, Opitz JM, et al. (2011). Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A 108: 6543-6548.
91. Pierce SB, Gersak K, Michaelson-Cohen R, Walsh T, Lee MK, Malach D, et al. (2013). Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in perrault syndrome. Am J Hum Genet 92: 614-620.
92. Pierson TM, Adams D, Bonn F, Martinelli P, Cherukuri PF, Teer JK, et al. (2011). Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genetics 7: e1002325.
93. Prasad C, Melancon SB, Rupar CA, Prasad AN, Nunez LD, Rosenblatt DS, et al. (2013). Exome sequencing reveals a homozygous mutation in TWINKLE as the cause of multisystemic failure including renal tubulopathy in three siblings. Mol Genet Metab 108: 190-194.
94. Rinaldi C, Grunseich C, Sevrioukova IF, Schindler A, Horkayne-Szakaly I, Lamperti C, et al. (2012). Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. Am J Hum Genet 91: 1095-1102.
95. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P, (1996). Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242: 84-89.
96. Ronchi D, Di Fonzo A, Lin W, Bordoni A, Liu C, Fassone E, et al. (2013). Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am J Hum Genet 92: 293-300.
97. Rotig A, (2011). Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta 1807: 1198-1205.
98. Salmela E, Lappalainen T, Fransson I, Andersen PM, Dahlman-Wright K, Fiebig A, et al. (2008). Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS ONE 3: e3519.
99. Sambuughin N, Liu X, Bijarnia S, Wallace T, Verma IC, Hamilton S, et al. (2013). Exome sequencing reveals SCO2 mutations in a family presented with fatal infantile hyperthermia. J Hum Genet 58: 226-228.
100. Sanger F, Nicklen S, Coulson AR, (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74: 5463-5467.
101. Schon EA, DiMauro S, Hirano M, (2012). Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet 13: 878-890.
102. Serre V, Rozanska A, Beinat M, Chretien D, Boddaert N, Munnich A, et al. (2013). Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency. Biochim Biophys Acta 1832: 1304-1312.
103. Shamseldin HE, Alshammari M, Al-Sheddi T, Salih MA, Alkhalidi H, Kentab A, et al. (2012). Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. J Med Genet 49: 234-241.
104. Shendure J, Lieberman Aiden E, (2012). The expanding scope of DNA sequencing. Nat Biotechnol 30: 1084-1094.
105. Shendure J, Mitra RD, Varma C, Church GM, (2004). Advanced sequencing technologies: methods and goals. Nat Rev Genet 5: 335-344.
106. Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP, Rosenbaum AM, et al. (2005). Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309: 1728-1732.
107. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. (2001). dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
108. Shimazaki H, Takiyama Y, Ishiura H, Sakai C, Matsushima Y, Hatakeyama H, et al. (2012). A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet 49: 777-784.
109. Sikkema-Raddatz B, Johansson LF, de Boer EN, Almomani R, Boven LG, van den Berg MP, et al. (2013). Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat 34: 1035-1042.
110. Siriwardena K, Mackay N, Levandovskiy V, Blaser S, Raiman J, Kantor PF, et al. (2013). Mitochondrial citrate synthase crystals: novel finding in Sengers syndrome caused by acylglycerol kinase (AGK) mutations. Mol Genet Metab 108: 40-50.
111. Skladal D, Halliday J, Thorburn DR, (2003). Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126 (Pt 8): 1905-1912.
112. Small I, Peeters N, Legeai F, Lurin C, (2004). Predotar: a tool for rapidly screening proteomes for N-terminal targeting sequences. Proteomics 4: 1581-1590.
113. Spiegel R, Pines O, Ta-Shma A, Burak E, Shaag A, Halvardson J, et al. (2012). Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Am J Hum Genet 90: 518-523.
114. Steenweg ME, Ghezzi D, Haack T, Abbink TE, Martinelli D, van Berkel CG, et al. (2012). Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. Brain 135 (Pt 5): 1387-1394.
115. Sulonen AM, Ellonen P, Almusa H, Lepisto M, Eldfors S, Hannula S, et al. (2011). Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 12: R94.
116. Suomalainen A, Syvanen AC, (2000). Quantitative analysis of human DNA sequences by PCR and solid-phase minisequencing. Mol Biotechnol 15: 123-131.
117. Szczesny RJ, Hejnowicz MS, Steczkiewicz K, Muszewska A, Borowski LS, Ginalski K, et al. (2013). Identification of a novel human mitochondrial endo-/exonuclease Ddk1/c20orf72 necessary for maintenance of proper 7S DNA levels. Nucleic Acids Res 41: 3144-3161.
118. Takata A, Kato M, Nakamura M, Yoshikawa T, Kanba S, Sano A, et al. (2011). Exome sequencing identifies a novel missense variant in RRM2B associated with autosomal recessive progressive external ophthalmoplegia. Genome Biol 12: R92.
119. Thorburn DR, (2004). Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27: 349-362.
120. Tucker EJ, Compton AG, Thorburn DR, (2010). Recent advances in the genetics of mitochondrial encephalopathies. Curr Neurol Neurosci Rep 10: 277-285.
121. Tucker EJ, Hershman SG, Kohrer C, Belcher-Timme CA, Patel J, Goldberger OA, et al. (2011). Mutations in MTFMT underlie a human disorder of formylation causing impaired mitochondrial translation. Cell Metab 14: 428-434.
122. Turnpenny PD, Ellard S, (2011). Emery's Elements of Medical Genetics, 14th edn. Elsevier: Philadelphia, PA.
123. Tyynismaa H, Sun R, Ahola-Erkkila S, Almusa H, Poyhonen R, Korpela M, et al. (2012). Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet 21: 66-75.
124. Vasta V, Merritt JL, 2nd, Saneto RP, Hahn SH, (2012). Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr Int 54: 585-601.
125. Vedrenne V, Gowher A, De Lonlay P, Nitschke P, Serre V, Boddaert N, et al. (2012). Mutation in PNPT1, which encodes a polyribonucleotide nucleotidyltransferase, impairs RNA import into mitochondria and causes respiratory-chain deficiency. Am J Hum Genet 91: 912-918.
126. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. (2001). The sequence of the human genome. Science 291: 1304-1351.
127. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, et al. (1988). Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427-1430.
128. Willemsen M, Rodenburg RJ, Teszas A, van den Heuvel L, Kosztolanyi G, Morava E, (2006). Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion 6: 155-159.
129. Wortmann SB, Vaz FM, Gardeitchik T, Vissers LE, Renkema GH, Schuurs-Hoeijmakers JH, et al. (2012). Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 44: 797-802.
130. Wu J, Jiang R, (2013). Prediction of deleterious nonsynonymous single-nucleotide polymorphism for human diseases. ScientificWorldJournal 2013: 675851. doi: 10.1155/2013/675851
131. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z, (2009). Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25: 2865-2871.
132. Ylikallio E, Suomalainen A, (2012). Mechanisms of mitochondrial diseases. Ann Med 44: 41-59.
133. Zerbino DR, Birney E, (2008). Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829.
134. Zheng L, Zhou M, Guo Z, Lu H, Qian L, Dai H, et al. (2008). Human DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA replication and repair intermediates. Mol Cell 32: 325-336.